Meropenem Bradex

Meropenem, the active ingredient in Meropenem Bradex, is a carbapenem antibiotic presented as an intravenous solution for IV use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, septicemia, and meningitis in hospitalized patients. It is indicated for use in adult and pediatric patients when alternative therapies are unsuitable.

GNH USA supplies Meropenem Bradex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, and pharmacies worldwide, with a focus on quality and regulatory compliance.

Meropenem Bradex is a carbapenem antibiotic used to treat serious bacterial infections across several organ systems.

- Complicated intra‑abdominal infections: Provides broad‑spectrum coverage to eradicate Gram‑negative, Gram‑positive and anaerobic pathogens. - Complicated urinary tract infections: Eliminates resistant uropathogens causing pyelonephritis and cystitis. - Nosocomial pneumonia: Treats hospital‑acquired lung infections, including ventilator‑associated pneumonia. - Septicemia: Offers rapid bactericidal activity in bloodstream infections. - Meningitis: Penetrates the cerebrospinal fluid to treat bacterial meningitis caused by susceptible organisms.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis. - Diarrhea: may be watery or loose. - Rash: skin erythema or pruritus. - Headache: transient cephalic discomfort. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Anaphylaxis: acute hypersensitivity reaction. - Renal toxicity: acute kidney injury in susceptible individuals. - Severe liver injury: rare hepatitis or cholestasis.

Use meropenem with caution and monitor patients for specific safety concerns.

- Renal impairment: adjust dose based on creatinine clearance. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Pregnancy: safety not established; weigh benefits against potential risks. - Seizure risk: monitor neurologic status, especially in patients with CNS disorders. - Liver function: check hepatic enzymes periodically. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate levels, increasing seizure risk. - Other carbapenems: concurrent use offers no added benefit and may increase toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance nephrotoxic potential. - Aminoglycosides: monitor renal function when combined. - Warfarin: observe INR for possible anticoagulation changes. - Oral contraceptives: efficacy may be reduced; consider alternative contraception.